Log in
Enquire now
BioLegend, Inc.

BioLegend, Inc.

BioLegend, Inc. is a company founded in 2002 by Gene Lay.

OverviewStructured DataIssuesContributors

Contents

biolegend.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Technology
Technology
Biology
Biology
Location
San Diego
San Diego
0
London
London
0
Tokyo
Tokyo
0
Amsterdam
Amsterdam
0
Beijing
Beijing
0
China
China
Founder
‌
Gene Lay
Pitchbook URL
pitchbook.com/profiles.../97057-00
Legal Name
BioLegend, Inc.
Email Address
cmonell@biolegend.com
Phone Number
+185845595880
+185876858000
+8640081971990
+187724653430
+813561580930
+4420347538800
Full Address
Pietersbergweg 289 1105 BM Amsterdam The Netherlands0
3F, Nihonseimei-kasugaekimae Bldg. Bunkyo-ku, Tokyo, 112-0002 Japan0
Room 31, 2nd Floor, Building 2 No.68 Beiqing Road, Haidian District Beijing, China0
8999 BioLegend Way San Diego, CA 92121 United States0
4B, 33 Greenwood Place London United Kingdom NW5 1LB0
DUNS Number
119240658
Founded Date
June 2002
Patents Assigned (Count)
3
Country
United States
United States
0
China
China
0
Japan
Japan
0
Netherlands
Netherlands
0
United Kingdom
United Kingdom
0

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like BioLegend, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.